Well out of my expertise I'm afraid, CP. I was surprised to hear Gary say the FDA only required 12 patients for our Ph2, but SNT went that bit extra with 15, so not really sure what to expect when they speak to the FDA to design the Ph3, following the Ph2 results. I'm sure it will require a larger patient pool, but just how large I don't know.
Well out of my expertise I'm afraid, CP. I was surprised to hear...
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $39.40M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.2¢ | $46.51K | 1.381M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 186766 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 196199 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |